Sessa Capital IM, L.P.

Position in FTRE — Fortrea Holdings Inc.

CIK 1595849 NEW YORK, NY

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$79,927,770

+$36,656,529 QoQ

Shares Held

4,593,550

0.0% QoQ

Ownership

4.83%

of shares outstanding

% of Portfolio

1.38%

of 13F equity value

Holder Rank

of 331 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Sessa Capital IM, L.P. holds $154,182,758 across 4 Biotechnology names. FTRE ranks #1 (51.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FTRE	Fortrea Holdings Inc. This page	4,593,550	$79,927,770
2	LXRX	Lexicon Pharmaceuticals, Inc.	18,960,836	$45,506,006
3	RNA	Atrium Therapeutics, Inc.	1,500,000	$20,175,000
4	SABS	SAB Biotherapeutics, Inc.	2,198,457	$8,573,982

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$79,927,770	4,593,550	0.0%	Shares	Sole	2026-08-14
2026-03-31	$43,271,241	4,593,550	+15.0%	Shares	Sole	2026-05-15
2025-12-31	$68,888,737	3,993,550	0.0%	Shares	Sole	2026-02-17
2025-09-30	$33,625,691	3,993,550	0.0%	Shares	Sole	2025-11-14
2025-06-30	$19,728,137	3,993,550	-14.9%	Shares	Sole	2025-08-13
2025-03-31	$35,436,302	4,693,550	-29.5%	Shares	Sole	2025-05-15
2024-12-31	$124,172,520	6,658,044	-3.6%	Shares	Sole	2025-02-14
2024-09-30	$138,160,880	6,908,044	+2.3%	Shares	Sole	2024-11-12
2024-06-30	$157,545,000	6,750,000	+5.9%	Shares	Sole	2024-08-14
2024-03-31	$255,892,500	6,375,000	0.0%	Shares	Sole	2024-05-15
2023-12-31	$222,487,500	6,375,000	+20.9%	Shares	Sole	2024-02-14
2023-09-30	$150,812,250	5,275,000	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.